Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
1.340
0.00 (0.00%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $3.48 million as of August 21, 2026. Its market cap has decreased by -59.98% in one year.
Market Cap
3.48M
Enterprise Value
1.35M
1-Year Change
-59.98%
Ranking
Category
Stock Price
$1.34
ChartMarket Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.83M to $3.48M, a decrease of -98.73%. That is a compound annual growth rate of -59.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 3.48M | -59.41% |
| Dec 31, 2025 | 8.56M | -61.46% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.45M | -64.38% |
| Dec 30, 2021 | 282.03M | 3.00% |
| Nov 1, 2021 | 273.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| VivoSim Labs | 4.25M |
| Silo Pharma | 4.21M |
| SciSparc | 3.84M |
| GRI Bio | 3.61M |
| Jupiter Neurosciences | 3.59M |
| Galmed Pharmaceuticals | 3.55M |
| Genprex | 3.24M |
| Artelo Biosciences | 3.18M |